A potential graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: Results from the French Bone Marrow Transplantation Society

Bone Marrow Transplantation

Volumn 31, Issue 10, 2003, Pages 909-918

  Esperou H ^a   Boiron, J M ^b   Cayuela, J M ^a   Blanchet, O ^c   Kuentz, M ^d   Jouet, J P ^e   Milpied, N ^f   Cahn, J Y ^g   Faucher, C ^h   Bourhis, J H ⁱ   Michallet, M ^j   Tanguy, M L ⁿ   Vernant, J P ^k   Gabert, J ^l   Bordigoni, P ^m,m   Ifrah, N ^c   Baruchel, A ^a   Dombert, H ^a   Devergie, A ^a   Gluckman, E ^a   Guardiola, Ph ^a   Leblanc, T ^a   Ribaud, P ^a   Rousselot, Ph ^a   Socie G ^a   Reiffers, J ^b   Cordonnier, C ^d   Beaune, J ^d   Yacoub Agha, I ^e   Deconinck, E ^g   Moreau, Ph ^f   Gueglio, B ^f   Jolibois, L ⁱ   Lheritier V ^j   Blaise, D ^k   Reportier, D ^h   Truchan Graczyk, M ^c   Dhedin, N ^k   Sutton, L ^k   Cornillot, M ^k   Attal, M ⁿ   Lioure, B ^o   Fegeux, N ^p   Quittet, Ph ^p   Rossi, J F ^p   Buzyn, A ^q   Fisher, A ^q   Hirsh, I ^q   Stamatoulas Bastard, A ^r   Tilly, H ^r   Guyotat, D ^l   Demeocq, F ^x   Stephan, J L ^x   Bay, J O ^x   Duval, M ^s   Vilmer, E ^s   Larche, R ^s   Garban, F ^t   Sotto, J J ^t   Sadoun, A ^u   Gratecos, N ^v   de Revel, T ^w   Nedellec, G ^w   more..

^a SAINT LOUIS HOSPITAL   (France)

^b HAUT LÉVÊQUE HOSPITAL   (France)

^c ANGERS UNIVERSITY HOSPITAL   (France)

^d HENRI MONDOR HOSPITAL   (France)

^e LILLE UNIVERSITY HOSPITAL   (France)

^f HÔTEL DIEU   (France)

^g UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^h INSTITUT PAOLI CALMETTES   (France)

ⁱ INSTITUT GUSTAVE ROUSSY   (France)

^j EDOUARD HERRIOT HOSPITAL   (France)

^k PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^l HÔPITAL NORD   (France)

^m HÔPITAL D ENFANTS   (France)

ⁿ CHU PURPAN   (France)

^o HÔPITAL DE HAUTEPIERRE   (France)

^p CENTRE HOSPITALIER   (France)

^q HÔPITAL NECKER ENFANTS MALADES   (France)

^r CENTRE HENRI BECQUEREL   (France)

^s HÔPITAL ROBERT DEBRÉ   (France)

^t HÔPITAL MICHALLON   (France)

^u University of Poitiers   (France)

^v CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^w PERCY MILITARY HOSPITAL   (France)

^x NONE

more..

Author keywords

Acute lymphoblastic leukemia; Graft versus leukemia effect; Hematopoietic stem cell transplantation; Minimal residual disease; Philadelphia chromosome

Indexed keywords

ALPHA INTERFERON; AMPHOTERICIN B; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ASPARAGINASE; BCR ABL PROTEIN; BETA LACTAM ANTIBIOTIC; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; MELPHALAN; MERCAPTOPURINE; METHOTREXATE; MITOXANTRONE; PENICILLIN G; POLYPEPTIDE ANTIBIOTIC AGENT; PREDNISONE; PROTEIN P120; STEROID; THIOTEPA; UNINDEXED DRUG; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ADVANCED CANCER; AGE; ALLOGRAFT; ARTICLE; BLOOD SAMPLING; BONE MARROW; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CHILD; CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DONOR; FEMALE; FRANCE; GENETIC TRANSCRIPTION; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HEMATOLOGICAL PARAMETERS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKEMIA REMISSION; LYMPHOCYTE TRANSFUSION; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MINIMAL RESIDUAL DISEASE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL TIME; TREATMENT FAILURE; TREATMENT OUTCOME; WHOLE BODY RADIATION;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; GRAFT VS LEUKEMIA EFFECT; HUMANS; INFANT; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; MALE; MIDDLE AGED; NEOPLASM, RESIDUAL; SOCIETIES, MEDICAL; STEM CELL TRANSPLANTATION; SURVIVAL RATE; TIME FACTORS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0037945476     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703951     Document Type: Article

References (39)

1. Tuszynski A, Dhut S, Young BD et al. Detection and significance of bcr-abl mRNA transcripts and fusion proteins in Philadelphia-positive adult acute lymphoblastic leukemia. Leukemia 1993; 7: 1504-1508.
2. Faderl S, Kantarjian HM, Talpaz M, Estrov Z. Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia. Blood 1998; 91: 3995-4019.
3. Suryanarayan K, Hunger SP, Kohler S et al. Consistent involvement of the bcr gene by 9;22 breakpoints in pediatric acute leukemias. Blood 1991; 77: 324-330.
4. Maurer J, Janssen JWG, Thiel E et al. Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction. Lancet 1991; 337: 1055-1058.
5. Radich J, Gehly G, Lee A et al. Detection of bcr-abl transcripts in Philadelphia chromosome-positive acute lymphoblastic leukemia after marrow transplantation. Blood 1997; 89: 2602-2609.
6. Bloomfield CD, Wurster-Hill D, Peng G et al. Prognostic significance of the Philadelphia chromosome in adult acute lymphoblastic leukemia. In: Gale RP, Hoelzer D (eds). Acute Lymphoblastic Leukemia. Alan R Liss: New York 1990, pp 101-109.
7. Groupe Français de Cytogénétique Hématologique. Cytogenetic abnormalities in adult acute lymphoblastic leukemia: correlations with hematologic findings and outcome. A collaborative study of the Groupe Français de Cytogénétique Hématologique. Blood 1996; 87: 3135-3142.
8. Beyermann B, Adams HP, Henze G. Philadelphia chromosome in relapsed childhood acute lymphoblastic leukemia: a matched-pair analysis. Berlin-Frankfurt-Munster Study Group. J Clin Oncol 1997; 15: 2231-2237.
9. Arico M, Valsecchi MG, Camitta B et al. Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. N Engl J Med 2000; 342: 998-1006.
10. Snyder DS. Allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Biol Blood Marrow Transplantation 2000; 6: 597-603.
11. Barrett AJ, Horowitz MM, Ash RC et al. Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 1992; 79: 3067-3070.
12. Dunlop LC, Powles R, Singhal S et al. Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Bone Marrow Transplant 1996; 3: 365-369.
13. Chao NJ, Blume KG, Forman SJ et al. Long-term follow-up of allogeneic bone marrow recipients for Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 1995; 85: 3353-3354.
14. Thomas X, Thiebaut A, Olteanu N et al. Philadelphia chromosome positive adult acute lymphoblastic leukemia: characteristics, prognostic factors and treatment outcome. Hematol Cell Ther 1998; 40: 119-128.
15. Marks DI, Bird JM, Cornish JM et al. Unrelated donor bone marrow transplantation for children and adolescents with Philadelphia-positive acute lymphoblastic leukemia. J Clin Oncol 1998; 16: 931-936.
16. Sierra J, Radich J, Hansen JA et al. Marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 1997; 90: 1410-1414.
17. Miyamura K, Tanimoto M, Morishima Y et al. Detection of Philadelphia chromosome positive acute lymphoblastic leukemia by polymerase chain reaction: possible eradication of minimal residual disease by marow transplantation. Blood 1992; 79: 1366-1370.
18. Preudhomme CN, Henic B, Cazin JL et al. Good correlation between RT-PCR analysis and relapse in Philadelphia-positive acute lymphoblastic leukemia. Leukemia 1997; 11: 294-298.
19. Michel G, Landman-Parker J, Auclerc MF et al. Use of recombinant human granulocyte colony-stimulating factor to increase chemaotherapy dose-intensity: a randomized trial in very high risk childhood acute lymphoblastic leukemia. J Clin Oncol 2000; 18: 1517-1524.
20. Ifrah N, Witz F, Jouet JP et al. Intensive short term therapy with granulocyte-macrophage colony-stimulating factor support, similar to therapy for acute myeloblastic leukemia, does not improve overall results for adults with acute lymphoblastic leukemia. GOELAMS Group. Cancer 1999; 86: 496-505.
21. Dombret H, Gabert J, Boiron JM et al. for the Groupe d'étude et de traitement de la leucémie aiguä lymphoblastique de l' adulte (GET-LAL group). Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the prospective multi-center LALA-94 trial. Blood 2002; 100: 2357-2366.
22. ISCN (International System for Human Cytogenetic Nomenclature). Guidelines for cancer cytogenetics. In: Mitelman F (ed.). Supplement to an International System for Human Cytogenetic Nomenclature. Karger: Basel, 1991, pp 1-53.
23. Kawasaki ES, Clark SS, Coyne MY et al. Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc Natl Acad Sci USA 1988; 85: 5698-5702.
24. Raynaud S, Mauvieux L, Cayuela JM et al. TEL-AML1 fusion gene is a rare event in adult acute lymphoblastic leukemia. Leukemia 1996; 10: 1529-1530.
25. van Dongen JJ, Macintyre EA, Gabert JA et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 concerted action: investigation of minimal residual disease in acute leukemia. Leukemia 1999; 13: 1901-1928 (Review).
26. Deconinck E, Cahn JY, Milpied N et al. Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia in first remission: long-term results for 42 patients conditioned with an intensified regimen (TBI, high-dose Ara-C and melphalan). Bone Marrow Transplant 1997; 9: 731-735.
27. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 4: 295-304.
28. Przepiorka D, Weisdorf D, Martin P et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 6: 825-828.
29. Flowers MED, Kansu E, Sullivan KM. Pathophysiology and treatment of graft-versus-host disease. Hematol Oncol Clin North Am 1999; 13: 1091.
30. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
31. Peto R, Peto J. Asymptotically efficient rank invariant test procedures. J R Stat Soc A 1972; 135: 185-206.
32. Cox DR. Regression models and life-tables. J R Stat Soc B 1972; 34: 187-220.
33. Annino L, Ferrari A, Cedrone M et al. Adult Philadelphia-chromosome-positive acute lymphoblastic leukemia: experience of treatments during a ten-year period. Leukemia 1994; 8: 664-667.
34. Faderl S, Kantarjian HM, Thomas DA et al. Outcome of Philadelphia chromosome-positive adult acute lymphoblastic leukemia. Leukemia Lymphoma 2000; 36: 263-273.
35. Uckun FM, Nachman JB, Sather HN et al. Clinical significance of Philadelphia chromosome positive pediatric acute lymphoblastic leukemia in the context of contemporary intensive therapies: a report from the Children's Cancer Group. Cancer 1998; 83: 2030-2039.
36. Snyder DS, Nademanee AP, O'Donnell MR et al. Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remission. Leukemia 1999; 13: 2053-2058.
37. Cornelissen JJ, Carston M, Kollman C et al. Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: strong graft-versus-leukemia effect and risk factors determining outcome. Blood 2001; 97:1572-1577.
38. Snyder DS, Negrin RS, Blume KG et al. Allogeneic bone marrow transplantation for BCR-ABL positive acute lymphoblastic leukemia [abstract]. Ann Hematol 1999; 78 (Suppl II): 59.
39. Kroger N, Kruger W, Wacker-Backhaus G et al. Intensified conditioning regimen in bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Bone Marrow Transplant 1998; 22: 1029-1033.